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ABSTRACT
The epigenome is a dynamic mediator of gene expression that shapes the way that cells, tissues, and organisms respond to
their environment. Initial studies in the emerging field of “toxicoepigenetics” have described either the impact of an
environmental exposure on the epigenome or the association of epigenetic signatures with the onset or progression of
disease; however, the majority of these pioneering studies examined the relationship between discrete epigenetic
modifications and the effects of a single environmental factor. Although these data provide critical blocks with which we
construct our understanding of the role of the epigenome in susceptibility and disease, they are akin to individual letters in
a complex alphabet that is used to compose the language of the epigenome. Advancing the use of epigenetic data to gain a
more comprehensive understanding of the mechanisms underlying exposure effects, identify susceptible populations, and
inform the next generation risk assessment depends on our ability to integrate these data in a way that accounts for their
cumulative impact on gene regulation. Here we will review current examples demonstrating associations between the
epigenetic impacts of intrinsic factors, such as such as age, genetics, and sex, and environmental exposures shape the
epigenome and susceptibility to exposure effects and disease. We will also demonstrate how the “epigenetic seed and soil”
model can be used as a conceptual framework to explain how epigenetic states are shaped by the cumulative impacts of
intrinsic and extrinsic factors and how these in turn determine how an individual responds to subsequent exposure to
environmental stressors.
Key words: epigenetics; chromatin; susceptibility; DNA methylation; seed and soil; developmental toxicity, prenatal;
reproductive and developmental toxicology; toxicoepigenetics.
The structure and function of cells, tissues, and organs is deter-
mined by the differential expression of approximately 20 000
genes (Pruitt et al., 2009), which must be regulated in a carefully
choreographed manner. The epigenome—a suite of covalent
modifications to DNA and its histone protein scaffolding—dic-
tates chromatin structure, interactions between the transcrip-
tional machinery and DNA, and ultimately gene expression
(Figure 1). Epigenetic modification of DNA is limited to methyla-
tion; however, while most commonly associated with gene si-
lencing (Baylin, 2005; Clark and Melki, 2002; Esteller, 2007;
Thienpont, et al., 2016; Venolia and Gartler, 1983), DNA methyla-
tion has a diverse range of roles in regulating gene expression
that vary with its genomic context (reviewed in Jones, 2012; Law
and Jacobsen, 2010; Smith and Meissner, 2013). In contrast to
DNA, histone proteins are decorated with a broad range of cova-
lent modifications, including methylation, acetylation, phos-
phorylation, ubiquitination, and many others (Kouzarides,
2007). In all, at least 130 unique epigenetic modifications have
been identified to date (Tan et al., 2011). Akin to the arrange-
ment of letters to form words in a language, these modification
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patterns function cooperatively as an epigenetic code that is
“written” through the enzymatic activities of epigenetic modify-
ing enzymes and “read” by specialized binding domains in tran-
scription factors and other chromatin-associated proteins
(Cedar and Bergman, 2009; Jenuwein and Allis, 2001; Strahl and
Allis, 2000). Patterns of activating modifications facilitate an
open chromatin structure (“euchromatin”) where DNA is acces-
sible to transcription factors, while patterns of repressive modi-
fications lead to compaction of chromatin structure
(“heterochromatin”) that obstructs binding of the transcrip-
tional machinery (Jenuwein and Allis, 2001).
The epigenetic code functions as a form of biological mem-
ory at the cellular level that directs both basal gene expression
and stimulus/exposure-responsive gene induction based on the
persistent epigenetic impacts of an individual’s chemical and
non-chemical environment. These patterns of epigenetic modi-
fications are both inherited, mitotically and meiotically, and ac-
quired as a result of intrinsic and extrinsic environmental
factors. As a result, the epigenome acts as a biosensor of an in-
dividual’s environment. The use of epigenetic data has the po-
tential to refine traditional methods for identifying at-risk
populations by providing a biomarker of how the cumulative
impact of an individual’s environmental history influences their
response to future exposures. Although promising, this pros-
pect has yet to be validated for practical application; however, it
has fueled the rapid expansion of toxicoepigenetics research
and led to the identification of novel putative links between en-
vironmental exposures, disease susceptibility, and public health
(Bollati and Baccarelli, 2010; Cortessis et al., 2012).
Early toxicoepigenetic studies have played a pivotal role in
demonstrating that environmental factors can alter the epige-
nome thus revising the epigenetic language that regulates gene
expression and susceptibility; however, these studies have typi-
cally focused on individual epigenetic markers, the equivalent
of a single letter in an alphabet containing at least 130 charac-
ters. Although each of these studies provides a letter in this reg-
ulatory language, the complexity of the epigenome requires the
incorporation of additional information to assemble a clear pic-
ture of how the environment shapes the regulation of gene ex-
pression and susceptibility to exposure-related disease.
Unfortunately, this complexity also engenders significant tech-
nical and practical challenges to simultaneously examining
multiple epigenetic markers within the regulatory regions of a
range of genes. Traditional approaches to identifying suscepti-
ble populations consider intrinsic factors such as age, sex, and
genotype. In recent years, greater consideration has been given
FIG. 1. Epigenetic modifications function in concert to regulate gene expression. A, Histone modifications and DNA methylation function cooperatively to regulate
chromatin structure, accessibility to transcription factors, and gene expression. DNA methylation is the addition of a methyl group by a DNMT to the cytosine residue
of CpG dinucleotides in DNA. Methylation of DNA in gene regulatory regions (promoters and enhancers) often results in transcriptional repression; however, the oxida-
tion of 5-methylcytosine to 5-hydroxymethylcytosine by the 10–11 translocation family of methylcytosine dioxygenases is associated with the activation of gene ex-
pression. The genome is packaged on a protein scaffolding composed of histone proteins arranged into repeating units known as nucleosomes. The unstructured tails
of these histones extend outside of the core nucleosome and are subject to numerous modifications such as acetylation, methylation, phosphorylation, ubiquitination,
et cetera. These modifications can be activating (eg, H3K4me3 and acetylation) or repressive/silencing (eg, H3K9me3 and H3K27me3). Activating histone acetylation and
methylation, modifications made by histone acetyltransferases and histone methyltransferases (HMTs), facilitate chromatin accessibility (euchromatin), recruitment
of the transcriptional machinery, including RNA polymerase II, and initiation/elongation of transcription. DNA methylation and repressive histone modifications func-
tion cooperatively, through proteins such as methyl-CpG binding protein 2, histone deacetylases, histone demethylases, and repressive HMTs, in the recruitment of
transcriptional co-repressors and the formation of repressed and inactive (heterochromatin) epigenetic states. B, Bivalent gene promoters regulate expression based
on the balance of activating and repressive histone modifications. Bivalent modifications occur in gene promoters (H3K4me3/H3K27me3) and enhancers (H3K27ac/
5mC) in both stem and somatic cells. The balance of otherwise opposing modifications determines whether a gene is repressed, poised (contains a paused polymerase
ready to initiate transcription), or actively expressed. This figure is a representation of the generalized functions of certain epigenetic factors; however, the functional-
ity of epigenetic modifications can vary based on the specific context in which they exist.
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to the role of the aggregate effects of extrinsic exposures (re-
ferred to as the “exposome”) in the alteration of physiological
processes and susceptibility to disease. Although these individ-
ual approaches provide valuable insight into aspects of suscep-
tibility, considering intrinsic and extrinsic factors separately
does not faithfully reflect the effects of an individual’s environ-
ment on health and disease susceptibility. Since both intrinsic
and extrinsic factors (collectively referred to as “environmental
factors”) impact the epigenome, we proposed the “epigenetic
seed and soil” model (Figure 2; adapted from McCullough et al.,
2016) as a conceptual framework that describes the cumulative
effects of environmental factors on susceptibility and exposure-
related disease by integrating their impact on the epigenome.
Here we will review literature that demonstrates the effects of
individual environmental factors on the epigenome and discuss
how the epigenetic seed and soil model can be used to explain
how the cumulative impact of environmental factors on the epi-
genome shapes exposure effects and susceptibility.
ENVIRONMENTAL FACTORS INFLUENCE THE
EPIGENOME
Age
An individual’s epigenome is constantly being reshaped
throughout his or her lifetime by two related processes known
as the epigenetic clock and epigenetic drift. Although epigenetic
changes associated with the epigenetic clock are programmed,
those associated with epigenetic drift result from the accumula-
tion of errors in epigenome maintenance. Common trends in
specific age-related DNA methylation changes across individ-
uals have been described as the “epigenetic clock” (Wilson et al.,
1987; reviewed in Jones et al., 2015). Although this epigenetic
clock correlates with chronological age (Hannum et al., 2013;
Horvath et al, 2012; Horvath, 2013; Smith et al., 2014), it advances
more slowly in those with relatively “healthier” lifestyles and
greater longevity (Gentilini et al., 2013; Marioni et al., 2015b) and
accelerated epigenetic age is associated with toxic exposures,
obesity, disease, and early mortality (Christiansen et al., 2016;
Faulk et al., 2014; Horvath, 2013; Horvath et al., 2014; Levine et al.,
2015; Marioni et al., 2015a).
The age-dependent accumulation of changes in epigenetic
modification states correlates with age-related changes in the
expression of key metabolic enzymes, such as the cytochrome
p450 (CYP) enzyme family (Giebel et al., 2016; Li et al., 2009) and
may play a critical role in lifestage-dependent windows of sus-
ceptibility (de Magalh~aes et al., 2009). The diversity and abun-
dance of expressed CYPs changes as a function of age (Hakkola
et al., 1998; Parkinson et al., 2004; Stevens et al., 2003) and is an
important determinant of inter-individual variability in xenobi-
otic metabolism (Hughes et al., 1996; Johnson, 2003; Tre´luyer
et al., 2001). CYP3A7 is highly expressed in the fetal liver, yet by
two years of age its expression is barely detectable. Conversely,
hepatic CYP3A4 expression is low at birth but increases through
childhood and plateaus by adulthood (Stevens et al., 2003).
Giebel et al. (2016) attributed the ontogeny of CYP3A7 and 3A4
expression to changes in the balance of activating histone H3 ly-
sine 4 trimethylation (H3K4me3) and repressive (H3K27me3)
modification levels within the regulatory regions of these genes.
The post-natal increase in CYP3A4 expression corresponds to
an increase in H3K4me3 abundance, and thus a shift in the bal-
ance of H3K4me3/H3K27me3 in favor of gene expression after
birth. Similarly, the post-natal increase in H3K27me3 abun-
dance at the CYP3A7 locus in post-natal liver shifted the
H3K4me3/H3K27me3 balance in favor of repression. This
“bivalency”, the co-occupancy of both activating and repressive
epigenetic modifications, serves as a biological “switch” to regu-
late gene expression (described in Figure 1B). The age-dependent
changes in the H3K4me3/H3K27me3 balance regulate the expres-
sion of specific metabolic enzymes during development and
have significant consequences on xenobiotic metabolism, which
are particularly well documented for pediatric use of pharmaceu-
tical drugs (de Wildt, et al., 1999).
Genetics
Genetic variation between individuals is often assessed by ex-
amining single nucleotide polymorphisms (SNPs). These varia-
tions in DNA sequence can have functional consequences on
the epigenome and can be important arbiters of health and dis-
ease. SNPs within the regulatory regions of a gene, such as the
promoter or enhancer, can influence its expression by altering
CpG sites that are subject to DNA methylation or transcription
factor binding sites. Further, SNPs within the protein-coding re-
gions of epigenetic effector proteins—such as histone and DNA
modifying-enzymes and transcription factors—can alter the
epigenetic landscape across the epigenome by influencing bind-
ing and/or catalytic activity (Lemire et al., 2015; Tehranchi et al.,
2016). As a result, genetic polymorphisms play a notable role in
FIG. 2. The epigenetic seed and soil model. Individuals with different back-
grounds, representing unique combinations of intrinsic and extrinsic factors,
will have differing “epigenetic soil.” The “seed” represents the cellular signaling
arriving at a gene promoter, either homeostatic signaling or signaling arising
from an acute stimulus (eg, a toxicant exposure). In more responsive individuals,
the epigenetic soil is more receptive to the incoming seed, resulting in increased
gene transcription. Increases in gene transcription may either occur at baseline
(a result of homeostatic signaling) or in response to an acute stimulus.
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shaping inter-individual variability in the epigenome (Gertz
et al., 2011).
Genome-wide association and quantitative trait loci (QTL)
studies have identified important associations between SNPs
and disease phenotypes; however, these traditional approaches
often lack the ability to provide a mechanistic connection when
identified SNPs are located in noncoding regions (Visscher et al.,
2012). The incorporation of epigenetic information into genetic
analysis has provided insight into the role of SNPs in a range of
disease studies (Gamazon et al., 2013; Heyn et al., 2014; Jaffe
et al., 2016; Liu et al., 2013). Similar integrative approaches have
been used to describe the role of non-coding SNPs in the modu-
lating expression of susceptibility genes such as paraoxonase 1
(PON1), an arylesterase enzyme involved in lipid biodisposition,
antioxidant defense, and the hydrolysis of organophosphate
compounds. Individuals with reduced expression or activity of
PON1 are at an increased risk of a wide range of diseases includ-
ing vascular diseases, metabolic syndrome, Alzheimer’s dis-
ease, various cancers, and reduced capacity to metabolize
xenobiotics (Camps et al., 2009; Costa et al., 2003; Furlong et al.,
2010). Of the various PON1 polymorphisms, the SNP PON1T-108 is
the best predictor of gene expression; however, it is located in a
non-coding promoter region and genetic analyses were not suf-
ficient to identify the mechanism by which this SNP influenced
PON1 expression. By integrating epigenetic data, Huen et al.
(2015) determined that PON1T-108 was located in a CpG site and
reduced PON1 expression by increasing local DNA methylation.
Subsequent studies demonstrated that PON1T-108 disrupted the
binding of the transcription factor specificity protein 1 (Deakin
et al., 2003; Osaki et al., 2004) and reduced promoter activity,
which led to increased local DNA methylation. These studies,
demonstrate the capacity for genetic polymorphisms to impact
the epigenome within the regulatory regions of genes that play
important roles in the response to toxic exposures.
Sex
Males and females exhibit sex-specific expression of a wide
range of genes, including metabolic enzymes, which impact
both basic physiology and the response to environmental expo-
sures (reviewed in Anderson 2005; Rademaker 2001; Soldin and
Mattison, 2009; Tran et al., 1998). Sexually dimorphic gene ex-
pression is largely a function of endocrine differences between
males and females, especially in the liver where approximately
1000 genes, including many CYPs, exhibit sexually biased ex-
pression (Waxman and O’Connor 2006; Zhang et al., 2011).
Differences in the secretion of hormones, such as growth hor-
mone (GH), control the expression of many transcription fac-
tors, particularly signal transducer and activator of
transcription 5 (STAT5). The role of the GH-STAT5 axis, which
has been implicated in the regulation of as many as 75–82% of
hepatic sex-biased genes (Clodfelter et al., 2006), was recently
linked to sex-dependent differences in DNase hypersensitivity
(a measure of chromatin accessibility), 6 histone modifications
(activating H3K4me3, K27ac, K4me1, K36me3; repressive
K27me3, K9me), and the binding of five GH-regulated transcrip-
tion factors (Sugathan and Waxman, 2013). Enhancer regions of
male-biased genes were enriched for the “pioneer” transcription
factors forkhead box proteins A1 and/or A2 (FOXA1, FOXA2),
which facilitate the opening of chromatin. Increased accessibil-
ity was followed by the recruitment of additional transcription
factors such as STAT5 and deposition of activating histone
modifications (H3K27ac and H3K4me1). Aberrant expression of
female-biased genes in males was prevented by the enrichment
of both the repressive histone modification H3K27me3 and the
male-biased transcriptional repressor B-Cell CLL/Lymphoma 6
(BCL6). Female-specific gene expression was strongly driven by
the transcription factor cut-like homeobox 2 (CUX2), which can
interact with distinct factors to act as either a repressor or an
activator. To activate female-biased genes, CUX2 functions co-
operatively with STAT5 and FOXA2 to facilitate the removal of
repressive H3K27me3 at gene enhancers. Conversely, CUX2 sup-
presses male-biased genes by binding enhancer regions to pro-
mote repressive chromatin structure. Although further studies
are required to integrate the contributions of DNA methylation
and other histone modifications, the epigenome plays a clear
role in the sexually dimorphic gene expression.
Toxicant Exposures and Developmental
Reprogramming
The aforementioned intrinsic factors are intractable qualities
that influence an individual’s susceptibility to toxicant expo-
sure effects; however, environmental exposures also alter the
epigenome and impact susceptibility and disease. These factors
range from daily nutrition to overt toxicant exposures, but share
the potential to alter the epigenome. Broadly speaking, these
extrinsic factors can impact health through phenomena such as
epigenetic carcinogenesis, regulation of inflammation, and de-
velopmental reprogramming, among others. Carcinogenesis is a
frequently studied toxicological outcome, yet many carcinogens
are not directly genotoxic. Although the underlying mecha-
nisms have not yet been thoroughly described, the “epigenetic
model of carcinogenesis” (Feinberg, 2004; Koturbash et al., 2011)
postulates that epigenetic changes at cancer-associated genes
impair the normal cellular mechanisms that prevent carcino-
genic transformation. This model is supported by data demon-
strating that exposure to tobacco smoke, benzene, arsenic, or
nickel (reviewed in Koturbash et al., 2011; Ray et al., 2014) alters
the epigenome at cancer-associated genes such as p53, p16, and
Ras association domain family member 1 (Rassf1), making ex-
posed cells more susceptible to subsequent carcinogenic stim-
uli. Similarly, exposure to a range of air pollutants alters the
epigenome and expression of genes that are critical in regulat-
ing the balance between host defense and inflammatory dis-
ease (Bellavia et al., 2013; Bind et al., 2014; Madrigano et al., 2012;
Nadeau et al., 2010). Further, epigenetic modifications play key
roles in modulating responses to multiple exposures, such as
inflammatory adaptation and priming (Foster et al., 2007; Gazzar
et al., 2007). Many further examples exist and each theme could
constitute its own review; however, here we will focus on endo-
crine disruptor exposure studies because they offer some of the
most promising evidence for the potential use of the epigenome
as an indicator of long-term susceptibility due to the persistent
reprogramming that results from exposure. The studies dis-
cussed below provide examples of how multiple lines of evi-
dence can be integrated to assemble a more complete
understanding of the impacts of environmental exposures on
the epigenome. Further, the studies by Bredfeldt et al. (2010),
Greathouse et al. (2012), and Jefferson et al. (2013) adopt a target
gene-centered approach to evaluating the relationship between
exposure-induced epigenetic changes and the alternative regu-
lation of outcome-associated genes.
Developmental Reprogramming
Exposures that occur during sensitive periods of epigenetic re-
modeling, such as during pregnancy and early childhood, have
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been shown to reprogram the epigenome and predispose off-
spring to diseases later in life. Strong associations between de-
velopmental exposures, the epigenome, and adult disease come
from early exposure to endocrine disrupting chemicals (EDCs).
Endogenous hormones, such as estrogen, play an integral and
carefully choreographed role in regulating gene expression pro-
grams that are critical for normal development and reproduc-
tive function. These processes can be disrupted and
reprogrammed by early exposure to exogenous estrogen mi-
metic compounds (xenoestrogens), such as the synthetic estro-
gen diethylstilbestrol (DES), dietary phytoestrogen genistein,
and the ubiquitous consumer goods plasticizer, bisphenol-A
(BPA). Although DES was removed from the American pharma-
ceutical market due to adverse health effects from in utero expo-
sures, BPA and genistein are commonplace in the developed
world. Unlike analogous adult exposures, DES, BPA, and genis-
tein reprogram hormone-responsive gene expression and in-
crease the incidence of uterine abnormalities and neoplasia in
rodent developmental exposure models (Greathouse et al., 2008;
Jefferson et al., 2013; Li et al., 1997; Markey et al., 2005; Murray
et al., 2007; Newbold et al., 2007, 2012; Suen et al., 2016; Wang
et al., 2014). This reprogramming is thought to occur through
various changes in DNA methylation and histone modifications
(reviewed in Walker, 2011), which alter both basal gene expres-
sion and hormone-dependent gene induction. These changes in
transcriptional programs are thought to underlie developmen-
tal abnormalities (Jefferson et al., 2011) and the development of
neoplasia later in life, especially after the initiation of menses
in female mice when endogenous estrogen levels increase.
To explore the relationship between xenoestrogen exposure,
neoplasia, and the epigenome, Bredfeldt et al., (2010) and
Greathouse et al., (2008, 2012) modeled developmental DES, ge-
nistein, and BPA exposure in the Eker rats, a strain that is pre-
disposed to a common hormone-responsive uterine tumor
known as leiomyoma (Walker and Stewart, 2005). Although the
transcriptional reprogramming induced by all 3 EDCs required
estrogen receptor-a (ERa), only DES and genistein induced acti-
vation of “pre-genomic” ERa signaling through the PI3K/Akt ki-
nase pathway. The resulting phosphorylation and inactivation
of the histone methyltransferase enhancer of zeste homolog 2
(Ezh2) led to a global reduction in abundance of the repressive
histone modification H3K27me3 in the uteri of DES- and
genistein-exposed animals. Unlike DES and genistein, BPA ex-
posure increased global abundance of H3K27me3 and did not in-
crease the incidence of leiomyoma, despite being associated
with reproductive anomalies and other types of neoplasia in
other studies (Murray et al., 2007; Newbold et al., 2007; Wang
et al., 2014). As the catalytic component of the histone-
modifying polycomb repressive complex 2 Ezh2 plays a critical
role in embryonic development, differentiation, and the control
of bivalent gene promoters. Although the mechanisms through
which different xenoestrogens exert their effects on the epige-
nome varies, dysregulation of key regulatory histone modifica-
tion, such as H3K27me3, is likely to play an integral role in
developmental reprogramming.
A similar study in mice demonstrated that developmental
exposure to DES reprogrammed expression of a range of histone
modifying enzymes (Hdac1, Hdac2, Hdac3, Kat2a, Kat2b, Myst2,
and Kmt2b), DNA methyltransferases (Dnmt1 and Dnmt3a), and
a methylcytosine dioxygenase (Tet1) (Jefferson et al., 2013).
These changes in epigenetic modification enzymes coincided
with alterations in the abundance of the activating histone
modifications H3K9ac, H4K5ac, and H3K4me3 within the regula-
tory regions of cancer-associated genes that were permanently
up-regulated following developmental genistein exposure (Suen
et al., 2016). By examining multiple epigenetic aspects these
studies provide a more comprehensive perspective on the
mechanisms responsible for the xenoestrogen-induced persis-
tent reprogramming of gene expression and associated increase
in developmental abnormalities and cancer susceptibility later
in life.
CUMULATIVE EFFECTS OF ENVIRONMENTAL
FACTORS ON THE EPIGENOME
Relating Cumulative Epigenetic States to Exposure
Outcomes and Susceptibility
Unlike traditional approaches that rely on discrete factors such
as age, genotype, and disease state, using the epigenome as a
biomarker has the potential to provide a more comprehensive
perspective on susceptibility by integrating the cumulative im-
pacts of environmental factors. An individual’s epigenome is
composed of patterns of DNA methylation and histone modifi-
cations that are both inherited and acquired as a result of intrin-
sic and extrinsic environmental factors. Due to practical
limitations, the influence of environmental factors on the epige-
nome is typically studied individually; however, translating
their impact on exposure-mediated disease requires consider-
ation of the cumulative impacts of environment on the epige-
nome. We recently hypothesized that baseline epigenetic
modification states, an “epigenetic snapshot” in time reflecting
the cumulative influences of intrinsic and extrinsic factors on
the epigenome, could predict both basal and toxicant-induced
gene expression (McCullough et al., 2016). To test this hypothe-
sis we compared the relative baseline (pre-exposure) abundance
of specific epigenetic modifications in gene promoters with the
basal and pollutant-induced (ozone) expression of target genes
in a panel of donors using a primary bronchial epithelial cell
air-liquid interface exposure model. We found that distinct epi-
genetic signatures were associated with the magnitude of basal
and ozone-induced expression. Although not encompassing all
epigenetic modifications or genes, our findings demonstrate
that cumulative epigenetic states correlate with both basal and
toxicant-induced gene expression.
The Seed and Soil Model
Here we expand upon our previously proposed “epigenetic seed
and soil model” (McCullough et al., 2016), a conceptual frame-
work that describes the cumulative effects of environmental
factors on susceptibility and exposure-related disease by inte-
grating the cumulative impact of environmental exposures on
the epigenome (Figure 2). In this model, the “seed” represents
incoming cellular signal (either homeostatic or toxicant-
induced) and the “soil” represents the mosaic of epigenetic
modifications within the regulatory region of a given gene. The
epigenetic “soil” influences gene expression by either altering
basal gene expression or modulating the magnitude of gene in-
duction in response to an acute stimulus. In the first scenario,
environmental factors shape the epigenome within the regula-
tory region(s) of a gene, which alters basal expression by repro-
graming its response to normal homeostatic signals. In the
second scenario, environmentally mediated epigenetic changes
reprogram how inducible a gene will be in response to an acute
stimulus, such as toxicant exposure. If the cumulative effects of
intrinsic and extrinsic forces result in a more receptive epige-
netic soil (ie, contains modifications favoring gene
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transcription) then the stimulus induced-signal will be robust;
however, a less-receptive epigenetic soil will result in modest
induction. Thus the seed and soil model serves as a streamlined
approach to conceptualizing the functional consequences re-
sulting from the cumulative impact of environment-induced
epigenetic changes with respect to health, exposure effects, and
susceptibility (examples given in Table 1).
CONCLUSIONS AND FUTURE DIRECTIONS
Toxicoepigenetics is a rapidly emerging field of study that has
made great advances in associating a broad range of environ-
mental exposures with changes to the epigenome. The impact
of toxicoepigenetic studies within the basic science and risk as-
sessment communities will continue to grow as they evolve to
include a broader range of epigenetic modifications to develop a
more comprehensive understanding of how environmental fac-
tors shape the epigenome and thus exposure effects and sus-
ceptibility. Further, the identification of more complete
epigenetic susceptibility profiles will provide targets to facilitate
the exploration of causal links between environmental factors,
the epigenome, and health outcomes. The application of toxi-
coepigenetic data will rely heavily on forthcoming studies bridg-
ing current knowledge gaps (Figure 3), which will involve
addressing the following:
1. DNA methylation and histone modifications are often stud-
ied independently; however, future studies will benefit from
the integration of data related to both types of epigenetic
modifications due to their concerted roles in regulating gene
expression (Roadmap Epigenetics Consortium, 2015).
Further, current high-throughput methods for analyzing
global DNA methylation do not distinguish between 5-meth-
ylcytosine and its relatively abundant oxidation product 5-
hydroxymethylcytosine, which can play an opposing role in
gene regulation. Future studies would benefit from the in-
corporation of methods that distinguish the contributions of
these two types of DNA methylation with divergent
functions.
2. Most toxicoepigenetics studies have examined the relation-
ship between epigenetic states and basal gene expression;
however, this approach may overlook inducible genes that
also play critical roles in response to external insults. The
inclusion of both of these types of gene expression will give
a more comprehensive perspective on how differences in
epigenetic states shape exposure effects and susceptibility.
Current studies typically examine the effects of environ-
mental exposures on the epigenome at a single dose and
time. The expansion of these studies to include a range of
doses and exposure durations will facilitate the identifica-
tion of threshold doses and response times.
3. The majority of toxicoepigenomic studies have succeeded in
observing associations between environmental factors, epi-
genetic changes, and health outcomes. The impact of these
studies will be increased by further studies that directly as-
sess causal relationships between these factors (Figure 3)
(Birney et al., 2016).
4. High-throughput data have been instrumental in generating
hypotheses regarding the role of the epigenome in exposure
effects and susceptibility. The utility of these data will be in-
creased by complimentary studies that test the hypotheses
generated through focused approaches that determine
whether the identified epigenetic states are causative of as-
sociated health outcomes.
5. Controlling for cell populations, especially in blood samples,
is a major complicating factor as inadvertently measuring
different proportions of cell types could mislead the identifi-
cation of environmentally induced epigenetic changes
(Reinius et al., 2012). Ideally, cell sub-types should be sepa-
rated by biochemical or immunologically based techniques
prior to epigenetic analysis to avoid this potential flaw in the
information obtained; however, when not possible (eg,
when using previously stored samples), the development,
validation, and application of emerging post-hoc computa-
tional methods, such as those described by Houseman et al.
(2012), may allow for the interrogation of cell type specific
epigenetic changes in samples that contain mixtures of cell
types.
This review has provided a brief overview of how intrinsic
and extrinsic factors can influence the epigenome and thus
modulate exposure effects and disease susceptibility; however,
we have only described a subset here. This rapidly evolving
field has the potential to fundamentally change our under-
standing of the mechanisms underlying exposure effects and
how cumulative environmental history shapes susceptibility.
Reaching this potential will require continued innovation by
FIG. 3. Need for causal in addition to associative evidence in defining the relationship between epigenetic state, exposures, and health outcomes. The majority of cur-
rent epigenetics studies in public health demonstrate that intrinsic or extrinsic forces shape the epigenome, or describe associations between the epigenome and dis-
ease. Based on this information it is difficult to distinguish whether the epigenome has a role in disease development or is a biomarker of effect. In order to link the
epigenome with health outcomes, it is necessary to implement study designs that may be able distinguish these roles. In addition to high-throughput screening, addi-
tional experiments should identify functional changes in gene expression and how these changes lead to the resulting outcome or phenotype.
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researchers to overcome both technical and scientific chal-
lenges to definitively define causal roles for the epigenome in
exposure-related outcomes. Doing so will ultimately allow for
validation of the utility of epigenetic endpoints as indicators of
exposure, modulators of susceptibility, and predictors of ad-
verse health effects.
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